Description
This video transcript presents a session led by Samantha Downie, a PhD trainee specializing in metastatic bone disease (MBD) outcomes, at the BOA Congress. In her address, Downie discusses the evolving focus in orthopedic oncology from solely objective outcomes—like survival rates and complication rates—to subjective outcomes such as patient quality of life and pain management, which are crucial for terminal conditions like MBD. She highlights a study comparing patient outcomes across orthopedic oncology and general trauma care settings, revealing disparities in care levels and access to timely surgery.
Downie also explores the challenges faced while measuring surgical outcomes in MBD patients, acknowledging that mortality is not a reliable indicator of surgical success due to the terminal nature of the condition. Indicators of metalwork failure, early complications, and postoperative care are emphasized as significant metrics. Furthermore, she discusses the importance of patient-reported outcomes and quality performance indicators as tools for assessing and improving the standard of care received by MBD patients. Ultimately, Downie concludes with recommendations for standardizing care across different centers to ensure equitable treatment for all patients, driven by patients' priorities and experiences.